A newly published study in Telehealth and Medicine Today (THMT) explores how mobile health is reshaping the way adverse effects from oral cancer therapies are monitored—moving care beyond the clinic and closer to the patient.
Digital Transformation in Oncology: Monitoring of Adverse Effects of Oral Antineoplastics Agents through mHealth solutions: Prospective interventional study
Carlota de Miguel Barbero, RN, PhD, Elvira Gea Rodríguez, PharmD, PhD, Francesc Garcia
Cuyàs, MD, PhD
PDF HTML XML EPUB
Why this is worth your attention
As oncology care continues its shift toward oral therapies and home-based management, the question becomes how do we ensure safety, engagement, and continuity—at scale? This study provides a tested,
real world framework.
What you’ll discover
- A redesigned care model integrating mHealth into oncology workflows
- How patients engage with digital tools to manage treatment-related effects
- The role
of continuous communication between patients and care teams
- Measurable impact on patient experience, empowerment, and system efficiency
Why it’s citable
The article demonstrates a practical, structured, and measurable approach
through:
- A prospective interventional study design
- Clinical implementation within a national health system
- Application of validated evaluation frameworks
- Evidence supporting scalability in chronic disease
management
For researchers, policymakers, and digital health leaders, it offers credible, reference-ready insight into decentralized care delivery.
